Halfan

Active Ingredient(s): Halofantrine
FDA Approved: * July 24, 1992
Pharm Company: * GLAXOSMITHKLINE
Category: Malaria

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Halfan Overview

Halofantrine is a drug used to treat malaria. Halofantrine's structure contains a substituted phenanthrene, and is related to the antimalarial drugs quinine and lumefantrine. Marketed as Halfan, halofantrine is never used to prevent malaria and its mode of action is unknown, although a crystallographic study showed that it binds to hematin in vitro, suggesting a possible mechanism of action.[1] Halofantrine has also been shown to bind to plasmpesin, a haemoglobin degrading enz...

Read more Halfan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Halofantrine

Recent Halfan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Halofantrine
  • Tablet: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Halofantrine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA